|
🐜
|
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
20 auth.
Clifford R Jack,
J. S. Andrews,
Thomas G. Beach,
Teresa Buracchio,
B. Dunn,
Ana Graf,
Oskar Hansson,
Carole Ho,
William Jagust,
E. McDade,
...
J. Molinuevo,
O. Okonkwo,
Luca Pani,
M. Rafii,
P. Scheltens,
Eric R. Siemers,
H. Snyder,
R. Sperling,
C. Teunissen,
Maria C. Carrillo
|
8 |
2024 |
8
🐜
|
|
🐜
|
Revised criteria for the diagnosis and staging of Alzheimer's disease.
20 auth.
Clifford R. Jack,
Scott J Andrews,
THOMAS G. Beach,
Teresa Buracchio,
B. Dunn,
Ana Graf,
Oskar Hansson,
Carole Ho,
W. Jagust,
Eric McDade,
...
J. Molinuevo,
O. Okonkwo,
Luca Pani,
M. Rafii,
P. Scheltens,
Eric R. Siemers,
H. Snyder,
R. Sperling,
C. Teunissen,
Maria C. Carrillo
|
5 |
2024 |
5
🐜
|
|
🐢
|
Improving Alzheimer’s disease phase II clinical trials
9 auth.
Barry D. Greenberg,
Maria C. Carrillo,
J. Michael Ryan,
M. Gold,
Kim Gallagher,
M. Grundman,
...
Robert M. Berman,
T. Ashwood,
Eric R. Siemers
|
4 |
2013 |
4
🐢
|
|
🐜
|
Alzheimer's Disease Drug Development
126 auth.
Jeffrey Cummings,
J. Kinney,
H. Fillit,
K. Brunden,
Goodwell Nzou,
C. Ballatore,
Andrew A. Pieper,
J. S. Mazza-Lunn,
Diana R. Wetmore,
Eric R. Siemers,
Robert A. Dean,
J. E. Senetar,
J. Hitchcock,
R. Barton,
Marwan Sabbagh,
...
Jiong Shi,
P. Scheltens,
Niels Prins,
P. S. Aisen,
Rema Raman,
M. Rafii,
Reisa A. Sperling,
Ronald C. Petersen,
J. Bork,
Cyndy B Cordell,
John R Dwyer,
Gabe Goldfeder,
D. Lappin,
Richard Mohs,
Julie Neild,
R. Schillinger,
Jill Smith,
Katy Smith,
Leigh Zisko,
G. Vradenburg,
P. Ljubenkov,
Adam L Boxer,
Suzanne B. Hendrix,
J. Nicodemus‐Johnson,
Logan R Kowallis,
N. Knowlton,
S. Hennessey,
S. Dickson,
Saif-ur-Rahman Paracha,
W. Redden,
G. Grossberg,
Susan Catalano,
Arturo Aliaga,
PhD Cara Altimus,
PhD Rhoda Au,
MD Clive Ballard,
Mrc Psych,
PhD Mba Laurence Barker,
Gil Bashe,
PhD Jonathan Behr,
Jr. PhD Frank J. Belas,
MD Mph Memory Charles Bernick,
B. Center,
MD PhD Kaj Blennow,
MD Ramon Cacabelos,
PhD Maria C. Carrillo,
PhD Feixiong Cheng,
DO Emily D. Clark,
MD A. Claudio Cuello,
Mba Jayna Cummings,
MD ScD Jeffrey Cummings,
MD Neal R. Cutler,
PhD Lauren G. Friedman,
MD Frcpc Serge Gauthier,
Msf Armineh L. Ghazarian,
PhD Joshua Grill,
MD Kevin V. Grimes,
MD Willem de Haan,
PhD Todd Haim,
PhD John Harrison,
Amanda Hu,
BS Brenda Hug,
PhD Samantha E. John,
PhD Christian Jung,
PhD Roos J. Jutten,
MD Amir Kalali,
PhD Min Su Kang,
PhD Pragati Katiyar,
MD Diana Kerwin,
PhD Vijaya B. Kolachalama,
PhD Bruce Lamb,
PhD Jessica Langbaum,
JD Emily A. Largent,
A. L. Osse,
PhD Honghuang Lin,
PhD Andrew W. Lo,
PhD Zane Martin,
PhD Gassan Massarweh,
M. M. Dawn C. Matthews,
MD DSc Soeren Mattke,
PhD Emily A. S. Meyers,
PhD Daria Mochly-Rosen,
MD Michael F. Murphy,
PhD Scott C. Neu,
PhD Jessie Nicodemus-Johnson,
PhD Rachel Nosheny,
PhD Adrian Oblack,
PhD Julie Ottoy,
PhD Meriel Owen,
PhD Alan D. Palkowitz,
Ph.D Suzana Petanceska,
MD Anton P. Porsteinsson,
PhD Lorenzo Refolo,
PhD Henry Riordan,
MD Craig W. Ritchie,
MD Pedro Rosa-Neto,
PhD Laurie Ryan,
PhD Arnold Salazar,
MD Cristina Sampaio,
MD Swati Sathe,
MD Mark E. Schmidt,
MS Monica Shin,
PhD Heather M. Snyder,
Pharm D John J. Sramek,
Angela Su,
Janet Sultana,
M. B. B Pharm,
PhD Rudolph E. Tanzi,
PhD Arthur W. Toga,
PhD Alessio Travaglia,
MD Everhard Vijverberg
|
2 |
2022 |
2
🐜
|
|
🐜
|
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)
19 auth.
Bruce Albala,
Eline Appelmans,
Ramona Burress,
Susan De Santi,
Theresa Devins,
Gregory Klein,
Veronika Logovinsky,
Gerald P. Novak,
Kim Ribeiro,
Mark E. Schmidt,
...
Adam J. Schwarz,
David Scott,
S. Shcherbinin,
Eric R. Siemers,
Alessio Travaglia,
Christopher J. Weber,
Leah White,
Julie Wolf-Rodda,
A. Vasanthakumar
|
2 |
2023 |
2
🐜
|
|
🐜
|
Benefits and risks of FDA‐approved amyloid‐targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician‐patient engagement
16 auth.
D. Rentz,
P. Aisen,
Alireza Atri,
Janice Hitchcock,
Michael Irizarry,
Jaren Landen,
Brandy R. Matthews,
David S. Miller,
Simin Mahinrad,
Salvatore Napoli,
...
Hamid R Okhravi,
Ronald C. Petersen,
Eric R. Siemers,
Christopher J. Weber,
David C Weisman,
Maria C. Carrillo
|
1 |
2024 |
1
🐜
|
|
🐜
|
Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
11 auth.
Linda J. Van Eldik,
Eric R. Siemers,
Emily C. Collins,
Michael Gold,
David Henley,
Peter Johannsen,
...
Hans J. Möbius,
Melanie Shulman,
Jin Zhou,
Maria C. Carrillo,
Christopher J. Weber
|
0 |
2024 |
0
🐜
|
|
🐜
|
Decision making in clinical trials: Interim analyses, innovative design, and biomarkers
11 auth.
K. Welsh-Bohmer,
G. Kerchner,
S. Dhadda,
Miguel Garcia,
David S. Miller,
F. Natanegara,
...
L. L. Rakêt,
W. Robieson,
Eric R. Siemers,
M. Carrillo,
Christopher J. Weber
|
0 |
2023 |
0
🐜
|
